2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery …
G Hindricks, T Potpara, N Dagres, E Arbelo… - European heart …, 2021 - academic.oup.com
MicroRNAs (miRNAs) are small regulatory molecules post-transcriptionally suppressing
mRNA activity. Many miRNAs in various organisms have been cloned but many unknown …
mRNA activity. Many miRNAs in various organisms have been cloned but many unknown …
Effectiveness and safety of oral anticoagulants in older patients with atrial fibrillation: a systematic review and meta-analysis
M Grymonprez, S Steurbaut, TL De Backer… - Frontiers in …, 2020 - frontiersin.org
Background and Objective Atrial fibrillation (AF), the most common cardiac arrhythmia,
typically increases with age. Oral anticoagulants (OACs) are the cornerstone of treatment to …
typically increases with age. Oral anticoagulants (OACs) are the cornerstone of treatment to …
[HTML][HTML] Stroke prevention strategies in high-risk patients with atrial fibrillation
A Kotalczyk, M Mazurek, Z Kalarus… - Nature Reviews …, 2021 - nature.com
Effective stroke prevention with oral anticoagulation (OAC) is the cornerstone of the
management of patients with atrial fibrillation. The use of OAC reduces the risk of stroke and …
management of patients with atrial fibrillation. The use of OAC reduces the risk of stroke and …
Oral anticoagulants in extremely-high-risk, very elderly (> 90 years) patients with atrial fibrillation
TF Chao, CE Chiang, YH Chan, JN Liao, TJ Chen… - Heart Rhythm, 2021 - Elsevier
Background The prevalence and incidence of atrial fibrillation (AF) increase with age.
However, older patients often are denied oral anticoagulation (OAC), especially if they are …
However, older patients often are denied oral anticoagulation (OAC), especially if they are …
Real-world evidence: bridging gaps in evidence to guide payer decisions
MH Roberts, GT Ferguson - PharmacoEconomics-Open, 2021 - Springer
Randomized controlled trials (RCTs) are preferred by payers for health technology
assessments and coverage decisions. However, the inclusion of a highly selective patient …
assessments and coverage decisions. However, the inclusion of a highly selective patient …
Managing older people with atrial fibrillation and preventing stroke: a review of anticoagulation approaches
ABSTRACT Introduction Oral anticoagulants (OACs) are the cornerstone of stroke
prevention in atrial fibrillation (AF), but prescribing decisions in older people are …
prevention in atrial fibrillation (AF), but prescribing decisions in older people are …
Assessment of DOAC in GEriatrics (ADAGE study): rivaroxaban/apixaban concentrations and thrombin generation profiles in NVAF very elderly patients
G Foulon-Pinto, C Lafuente-Lafuente… - Thrombosis and …, 2023 - thieme-connect.com
Background Although a growing number of very elderly patients with atrial fibrillation (AF),
multiple conditions, and polypharmacy receive direct oral anticoagulants (DOACs), few …
multiple conditions, and polypharmacy receive direct oral anticoagulants (DOACs), few …
Direct oral anticoagulants versus warfarin in octogenarians with nonvalvular atrial fibrillation: a systematic review and meta-analysis
C Bonanad, S Garcia-Blas, J Torres Llergo… - Journal of clinical …, 2021 - mdpi.com
Direct oral anticoagulants (DOACs) have been demonstrated to be more effective and safer
than vitamin-K antagonist (VKA) for stroke prevention in patients with nonvalvular atrial …
than vitamin-K antagonist (VKA) for stroke prevention in patients with nonvalvular atrial …
Effectiveness and safety of edoxaban compared with apixaban in elderly patients with nonvalvular atrial fibrillation: a real-world population-based cohort study
R Chiv, S Beradid, S Suissa, C Renoux - Stroke, 2024 - Am Heart Assoc
BACKGROUND: The very elderly (≥ 80 years) are at high risk of nonvalvular atrial
fibrillation and thromboembolism. Given its recent approval, the comparative effectiveness …
fibrillation and thromboembolism. Given its recent approval, the comparative effectiveness …
Anticoagulation therapy for non-valvular atrial fibrillation: a mini-review
J Wu, Y Zhang, X Liao, Y Lei - Frontiers in medicine, 2020 - frontiersin.org
Anticoagulation therapy is an important method of preventing stroke in individuals with atrial
fibrillation (AF). Atrial fibrillation is a quivering or irregular heartbeat that can lead to blood …
fibrillation (AF). Atrial fibrillation is a quivering or irregular heartbeat that can lead to blood …